
Qiagen NV
NYSE:QGEN


to continue QGEN research
to continue QGEN research
You've reached your weekly stock limit.
Sign UpQiagen NV?
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
Retail
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
Energy
|
We'll email you a reminder when the closing price reaches USD.
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
37.82
48.64
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
![]() |
Johnson & Johnson
NYSE:JNJ
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
US |
![]() |
Nike Inc
NYSE:NKE
|
US |
![]() |
Visa Inc
NYSE:V
|
US |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.

What unique competitive advantages
does Qiagen NV hold over its rivals?
What risks and challenges
does Qiagen NV face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Provide an overview of the primary business activities
of Qiagen NV.
Provide an overview of the primary business activities
of Qiagen NV.
What unique competitive advantages
does Qiagen NV hold over its rivals?
What risks and challenges
does Qiagen NV face in the near future?
Has there been any significant insider trading activity
in Qiagen NV recently?
Summarize the latest earnings call
of Qiagen NV.
Is it considered overvalued or undervalued
based on the latest financial data?
Show all valuation multiples
for Qiagen NV.
Provide P/S
for Qiagen NV.
Provide P/E
for Qiagen NV.
Provide P/OCF
for Qiagen NV.
Provide P/FCFE
for Qiagen NV.
Provide P/B
for Qiagen NV.
Provide EV/S
for Qiagen NV.
Provide EV/GP
for Qiagen NV.
Provide EV/EBITDA
for Qiagen NV.
Provide EV/EBIT
for Qiagen NV.
Provide EV/OCF
for Qiagen NV.
Provide EV/FCFF
for Qiagen NV.
Provide EV/IC
for Qiagen NV.
Show me price targets
for Qiagen NV made by professional analysts.
What are the Revenue projections
for Qiagen NV?
How accurate were the past Revenue estimates
for Qiagen NV?
What are the Net Income projections
for Qiagen NV?
How accurate were the past Net Income estimates
for Qiagen NV?
What are the EPS projections
for Qiagen NV?
How accurate were the past EPS estimates
for Qiagen NV?
What are the EBIT projections
for Qiagen NV?
How accurate were the past EBIT estimates
for Qiagen NV?
Compare the revenue forecasts
for Qiagen NV with those of its competitors based on recent analyst estimates.
Compare the intrinsic valuations
of Qiagen NV and its key competitors using the latest financial data.
Compare historical revenue growth rates
of Qiagen NV against its competitors.
Analyze the profit margins
(gross, operating, and net) of Qiagen NV compared to its peers.
Compare the P/E ratios
of Qiagen NV against its peers.
Discuss the investment returns and shareholder value creation
comparing Qiagen NV with its peers.
Analyze the financial leverage
of Qiagen NV compared to its main competitors.
Show all profitability ratios
for Qiagen NV.
Provide ROE
for Qiagen NV.
Provide ROA
for Qiagen NV.
Provide ROIC
for Qiagen NV.
Provide ROCE
for Qiagen NV.
Provide Gross Margin
for Qiagen NV.
Provide Operating Margin
for Qiagen NV.
Provide Net Margin
for Qiagen NV.
Provide FCF Margin
for Qiagen NV.
Show all solvency ratios
for Qiagen NV.
Provide D/E Ratio
for Qiagen NV.
Provide D/A Ratio
for Qiagen NV.
Provide Interest Coverage Ratio
for Qiagen NV.
Provide Altman Z-Score Ratio
for Qiagen NV.
Provide Quick Ratio
for Qiagen NV.
Provide Current Ratio
for Qiagen NV.
Provide Cash Ratio
for Qiagen NV.
What is the historical Revenue growth
over the last 5 years for Qiagen NV?
What is the historical Net Income growth
over the last 5 years for Qiagen NV?
What is the current Free Cash Flow
of Qiagen NV?
Discuss the annual earnings per share (EPS)
trend over the past five years for Qiagen NV.
EV/EBITDA
Enterprise Value to EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.
Market Cap | EV/EBITDA | ||||
---|---|---|---|---|---|
NL |
![]() |
Qiagen NV
NYSE:QGEN
|
10.4B USD | 15.2 | |
US |
P
|
PerkinElmer Inc
LSE:0KHE
|
1.1T USD | 1 398.1 |
|
US |
![]() |
Thermo Fisher Scientific Inc
NYSE:TMO
|
164.2B USD | 17.5 |
|
US |
![]() |
Danaher Corp
NYSE:DHR
|
146.6B USD | 21.4 |
|
KR |
![]() |
Samsung Biologics Co Ltd
KRX:207940
|
71.2T KRW | 32.3 |
|
CH |
![]() |
Lonza Group AG
SIX:LONN
|
39.4B CHF | 22.7 |
|
US |
![]() |
Agilent Technologies Inc
NYSE:A
|
35B USD | 20.3 |
|
CN |
![]() |
WuXi AppTec Co Ltd
SSE:603259
|
222.8B CNY | 19.3 |
|
US |
![]() |
IQVIA Holdings Inc
NYSE:IQV
|
28.4B USD | 11.7 |
|
US |
![]() |
Mettler-Toledo International Inc
NYSE:MTD
|
25.5B USD | 22.3 |
|
FR |
![]() |
Sartorius Stedim Biotech SA
PAR:DIM
|
19.8B EUR | 30.9 |
|
EBITDA Growth | EV/EBITDA to Growth | |||||
---|---|---|---|---|---|---|
NL |
![]() |
Qiagen NV
NYSE:QGEN
|
Average EV/EBITDA:
146.5
15.2
|
10%
|
1.5 | |
US |
P
|
PerkinElmer Inc
LSE:0KHE
|
1 398.1
|
7%
|
199.7 |
|
US |
![]() |
Thermo Fisher Scientific Inc
NYSE:TMO
|
17.5
|
6%
|
2.9 |
|
US |
![]() |
Danaher Corp
NYSE:DHR
|
21.4
|
7%
|
3.1 |
|
KR |
![]() |
Samsung Biologics Co Ltd
KRX:207940
|
32.3
|
17%
|
1.9 |
|
CH |
![]() |
Lonza Group AG
SIX:LONN
|
22.7
|
18%
|
1.3 |
|
US |
![]() |
Agilent Technologies Inc
NYSE:A
|
20.3
|
10%
|
2 |
|
CN |
![]() |
WuXi AppTec Co Ltd
SSE:603259
|
19.3
|
24%
|
0.8 |
|
US |
![]() |
IQVIA Holdings Inc
NYSE:IQV
|
11.7
|
9%
|
1.3 |
|
US |
![]() |
Mettler-Toledo International Inc
NYSE:MTD
|
22.3
|
4%
|
5.6 |
|
FR |
![]() |
Sartorius Stedim Biotech SA
PAR:DIM
|
30.9
|
20%
|
1.5 |
|
EV/EBITDA Forward Multiples
Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.